FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080261619> ?p ?o ?g. }

• W3080261619 endingPage "B16" @default.
• W3080261619 startingPage "B16" @default.
• W3080261619 abstract "Abstract High-grade serous ovarian cancer remains deadly for the majority of woman who are diagnosed every year. The high mortality rate necessitates new treatment options for physicians and patients to consider. To produce new therapies, different signaling pathways that are activated in ovarian cancer need to be identified. In order to mimic the growth of ovarian cancer in the body, 3D culturing systems were used to grow clusters of ovarian cells (spheroids). Comparing gene expression from cells grown in 2D and 3D, we identified the STAT3 signaling pathway as being highly enriched in ovarian spheroids. STAT3 is a transcription factor that is activated by tyrosine phosphorylation. Once phosphorylated, STAT3 dimerizes, translocates to the nucleus, and regulates the expression of many genes involved in cell survival and migration. To determine if STAT3 was activated in 3D growing cells, we analyzed protein from cells grown in 2D and 3D and determined that STAT3 was tyrosine phosphorylated in cells grown in 3D We have found that the increase in STAT3 phosphorylation in 3D grown cells was associated with increased expression of STAT3 target genes. Consistent with this, we found enhanced STAT3 DNA binding to regulatory regions of STAT3 target genes. Recognizing that STAT3 activation is upregulated in 3D, we wanted to know if STAT3 is necessary for growth in 3D. By using siRNA to reduce the expression of STAT3, we were able to hinder the ability for ovarian cancer to grow in 3D. Moreover, reducing the expression of various components in the STAT3 signaling pathway also reduced the growth of ovarian spheroids. One of the major steps in ovarian cancer metastasis is the clearance of mesothelial cells by the cancer cells. To assess the effects of enhanced STAT3 activity in spheroids, we performed a mesothelial clearance assay with spheroids containing and lacking STAT3 expression. We found that ovarian spheroids with reduced STAT3 expression had a decreased ability to metastasize. This suggests that the STAT3 signaling pathway is a critical pathway involved in the growth and metastasis of ovarian cancer spheroids. This raises the possibility of using STAT3 inhibitors by themselves or in conjunction with standard-of-care therapeutics in the treatment of advanced ovarian cancer. Thus, targeting signaling pathways important in 3D growth may be beneficial for the treatment of ovarian cancer. Citation Format: David F. Walker, Sarah J. Lacroix, Zachary T. Giaccone, David A. Frank, Sarah R. Walker. STAT3 promotes ovarian cancer spheroid growth and metastasis [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research; 2019 Sep 13-16, 2019; Atlanta, GA. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(13_Suppl):Abstract nr B16." @default.
• W3080261619 created "2020-09-01" @default.
• W3080261619 creator A5018988739 @default.
• W3080261619 creator A5046797103 @default.
• W3080261619 creator A5047880272 @default.
• W3080261619 creator A5079727834 @default.
• W3080261619 creator A5086809025 @default.
• W3080261619 date "2020-07-01" @default.
• W3080261619 modified "2023-10-11" @default.
• W3080261619 title "Abstract B16: STAT3 promotes ovarian cancer spheroid growth and metastasis" @default.
• W3080261619 doi "https://doi.org/10.1158/1557-3265.ovca19-b16" @default.
• W3080261619 hasPublicationYear "2020" @default.
• W3080261619 type Work @default.
• W3080261619 sameAs 3080261619 @default.
• W3080261619 citedByCount "0" @default.
• W3080261619 crossrefType "journal-article" @default.
• W3080261619 hasAuthorship W3080261619A5018988739 @default.
• W3080261619 hasAuthorship W3080261619A5046797103 @default.
• W3080261619 hasAuthorship W3080261619A5047880272 @default.
• W3080261619 hasAuthorship W3080261619A5079727834 @default.
• W3080261619 hasAuthorship W3080261619A5086809025 @default.
• W3080261619 hasConcept C11960822 @default.
• W3080261619 hasConcept C121608353 @default.
• W3080261619 hasConcept C2777553839 @default.
• W3080261619 hasConcept C2778923194 @default.
• W3080261619 hasConcept C2779013556 @default.
• W3080261619 hasConcept C2780427987 @default.
• W3080261619 hasConcept C502942594 @default.
• W3080261619 hasConcept C54355233 @default.
• W3080261619 hasConcept C62112901 @default.
• W3080261619 hasConcept C62478195 @default.
• W3080261619 hasConcept C71924100 @default.
• W3080261619 hasConcept C86803240 @default.
• W3080261619 hasConcept C95444343 @default.
• W3080261619 hasConceptScore W3080261619C11960822 @default.
• W3080261619 hasConceptScore W3080261619C121608353 @default.
• W3080261619 hasConceptScore W3080261619C2777553839 @default.
• W3080261619 hasConceptScore W3080261619C2778923194 @default.
• W3080261619 hasConceptScore W3080261619C2779013556 @default.
• W3080261619 hasConceptScore W3080261619C2780427987 @default.
• W3080261619 hasConceptScore W3080261619C502942594 @default.
• W3080261619 hasConceptScore W3080261619C54355233 @default.
• W3080261619 hasConceptScore W3080261619C62112901 @default.
• W3080261619 hasConceptScore W3080261619C62478195 @default.
• W3080261619 hasConceptScore W3080261619C71924100 @default.
• W3080261619 hasConceptScore W3080261619C86803240 @default.
• W3080261619 hasConceptScore W3080261619C95444343 @default.
• W3080261619 hasIssue "13_Supplement" @default.
• W3080261619 hasLocation W30802616191 @default.
• W3080261619 hasOpenAccess W3080261619 @default.
• W3080261619 hasPrimaryLocation W30802616191 @default.
• W3080261619 hasRelatedWork W1576402354 @default.
• W3080261619 hasRelatedWork W1898795080 @default.
• W3080261619 hasRelatedWork W1985211644 @default.
• W3080261619 hasRelatedWork W1988749775 @default.
• W3080261619 hasRelatedWork W2022006194 @default.
• W3080261619 hasRelatedWork W2072299589 @default.
• W3080261619 hasRelatedWork W2087695146 @default.
• W3080261619 hasRelatedWork W2122000206 @default.
• W3080261619 hasRelatedWork W2168402415 @default.
• W3080261619 hasRelatedWork W2422873599 @default.
• W3080261619 hasVolume "26" @default.
• W3080261619 isParatext "false" @default.
• W3080261619 isRetracted "false" @default.
• W3080261619 magId "3080261619" @default.
• W3080261619 workType "article" @default.